Pekka Sillanaukee (original) (raw)
Pekka Sillanaukee (born 1964, Tampere Finland) is a Finnish health technology entrepreneur. Pekka graduated as an organic chemist in 1989, he became a Ph.D. in 1992 and was appointed Docent of Medical Biochemistry at the Faculty of Medicine of the University of Tampere in 1993. Pekka has been a co-author of approximately 120 scientific original articles, reviews or summaries. His scientific work has focused on clinical and medical biochemistry, alcohol, brain and cardiovascular related diseases, and development of laboratory-diagnostic tests and processes. He also has four international patents.
| Property | Value |
|---|---|
| dbo:abstract | Pekka Sillanaukee (born 1964, Tampere Finland) is a Finnish health technology entrepreneur. Pekka graduated as an organic chemist in 1989, he became a Ph.D. in 1992 and was appointed Docent of Medical Biochemistry at the Faculty of Medicine of the University of Tampere in 1993. Pekka has been a co-author of approximately 120 scientific original articles, reviews or summaries. His scientific work has focused on clinical and medical biochemistry, alcohol, brain and cardiovascular related diseases, and development of laboratory-diagnostic tests and processes. He also has four international patents. Pekka has worked as a researcher at the Medical School of the University of Tampere and at Tampere University Hospital, as a responsible clinical researcher at Alko's research laboratories from 1987 to 1993, then as a director and business unit member at Pharmacia & Upjohn Inc. (Pfizer) 1994-1999, CEO at FIT Biotech Plc 1999-2004, and thereafter as an entrepreneur, co-founder or co-owner of different Finnish, Swedish and Estonian health technology and service companies including Bioretec Ltd, ESO International Ltd, Innokas Medical Ltd, Nordic Senior Services Ltd, Nova Vita Ltd, OS-Service, Ovumia Ltd, Palvelutähti Ltd, Paavolankoti Ltd, and Quattromed Ltd. Since 2014 Sillanaukee has focused on the development of fertility treatment technologies and practices in Ovumia Fertility Clinic. (en) |
| dbo:wikiPageID | 54919760 (xsd:integer) |
| dbo:wikiPageLength | 4843 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID | 1100024221 (xsd:integer) |
| dbo:wikiPageWikiLink | dbc:University_of_Tampere_alumni dbr:Pfizer dbr:University_of_Jyväskylä dbr:University_of_Tampere dbc:Living_people dbr:Organic_chemistry dbc:Finnish_biochemists dbr:London_Business_School dbc:1964_births dbr:Health_technology dbr:Aalto_University dbr:Finland dbr:Tampere dbc:University_of_Jyväskylä_alumni dbr:Karolinska_Institute dbr:Fertility_treatment dbr:Helsinki_School_of_Economics_and_Business_Administration dbr:Stockholm_School_of_Economics_and_Business_Administration |
| dbp:wikiPageUsesTemplate | dbt:Authority_control dbt:BLP_sources dbt:COI dbt:Multiple_issues dbt:Reflist dbt:Short_description |
| dcterms:subject | dbc:University_of_Tampere_alumni dbc:Living_people dbc:Finnish_biochemists dbc:1964_births dbc:University_of_Jyväskylä_alumni |
| rdf:type | owl:Thing |
| rdfs:comment | Pekka Sillanaukee (born 1964, Tampere Finland) is a Finnish health technology entrepreneur. Pekka graduated as an organic chemist in 1989, he became a Ph.D. in 1992 and was appointed Docent of Medical Biochemistry at the Faculty of Medicine of the University of Tampere in 1993. Pekka has been a co-author of approximately 120 scientific original articles, reviews or summaries. His scientific work has focused on clinical and medical biochemistry, alcohol, brain and cardiovascular related diseases, and development of laboratory-diagnostic tests and processes. He also has four international patents. (en) |
| rdfs:label | Pekka Sillanaukee (en) |
| owl:sameAs | wikidata:Pekka Sillanaukee dbpedia-fi:Pekka Sillanaukee https://global.dbpedia.org/id/3VEQq |
| prov:wasDerivedFrom | wikipedia-en:Pekka_Sillanaukee?oldid=1100024221&ns=0 |
| foaf:isPrimaryTopicOf | wikipedia-en:Pekka_Sillanaukee |
| is dbo:wikiPageWikiLink of | dbr:University_of_Tampere |
| is foaf:primaryTopic of | wikipedia-en:Pekka_Sillanaukee |